News & Events

• May 6, 2013

  ETView Medical, Ltd., and Mercury Medical, Inc., (Mercury), Execute Distribution Agreement

  more »

• March 30, 2013

  ETView, Ltd. received US FDA Clearance of a 510(k) Pre-marketing Notification Application Expanding the VivaSight™-DL line of Innovative Airway Devices.

  more »

• March 18, 2013

  ETView Medical, Ltd. announces China State Food and Drug Administration (SFDA) clearance of a pre-marketing notification application for the VivaSight™-SL line of innovative airway devices.

  more »

• July 2, 2012

  ETView Medical, Ltd. announced CE clearance for the VivaSight™-EB, was previously known as Viva™-EB, line of innovative endobronchial blockers

  more »

• June 25, 2012

  ETView Medical, Ltd. announced CE clearance for the VivaSight™‐DL line of innovative airway devices

  more »

• June 4, 2012

  ETView Medical, Ltd. announced appointment of David Amar, MD, to its scientific advisory board

  more »

• May 23, 2012

  ETView Medical, Ltd. announced US FDA clearance of a 510(k) pre-marketing notification application for the VivaSight™-DL line of innovative airway devices

  more »

• April 23, 2012

  ETView Medical, Ltd. and Champ Medics Co., Ltd. (Champ Medics) executed distribution agreement

  more »

• April 9, 2012

  ETView Medical, Ltd., and Medutech S.A. DE C.V. (Medutech) execute distribution agreement

  more »

• March 19, 2012

  ETView Medical, Ltd., and Amphar b.v. (Amphar) executed distribution agreement

  more »

• March 12, 2012

  ETView Medical, Ltd. announced KFDA pre-market clearance for the VivaSight™-SL line of innovative airway devices

  more »

• March 5, 2012

  ETView Medical, Ltd., announced filing of a technical file, initiating CE clearance for the Viva™ EB line of innovative endobronchial blockers

  more »

• February 20, 2012

  ETView Medical, Ltd. announced exclusive patent license agreement

  more »

• February 7, 2012

  ETView Medical, Ltd. and NeuroMed Ltd. (NeuroMed) executed distribution agreement

  more »

• February 6, 2012

  ETView Medical, Ltd., announced filing of a 510(k) pre-marketing notification application with the US Food and Drug administration for the Viva™ EB line of innovative endobronchial blockers.

  more »

• February 2, 2012

  ETView Medical, Ltd., and State of the Art (SOTA) Medical Products, Inc., executed distribution agreement

  more »

• December 12, 2011

  ETView Medical, Ltd. announced filing of a 510(k) pre-marketing notification application with the US Food and Drug Administration for the VivaSight™-DL line of innovative airway management devices

  more »

• July 25, 2011

  ETView announced appointment of Javier Campos, MD, to its scientific advisory board.

  more »